Comparative efficacy and safety of injection mucosa knife versus conventional techniques in endoscopic submucosal dissection for rectal laterally spreading tumors

注射式黏膜刀与传统技术在内镜黏膜下剥离术治疗直肠侧向扩展型肿瘤中的疗效和安全性比较

阅读:2

Abstract

Endoscopic submucosal dissection (ESD) is a standard treatment for rectal laterally spreading tumors (LSTs). This study aims to compare the efficacy and safety of the Injection Mucosa Knife (IMK) technique versus the conventional Dual Knife (DK) technique in ESD for rectal LSTs. A total of 229 patients with rectal LSTs were enrolled from four hospitals between June 2020 and June 2025 and were divided into two groups: the IMK group (n = 108) and the DK group (n = 121). The primary outcome measures included total procedure time, mucosal dissection time, and submucosal dissection rate, while the secondary outcomes encompassed intraoperative and postoperative complications as well as the R0 resection rate. Additionally, the efficacy and safety of the two groups were compared based on tumor size and endoscopic morphology. The IMK group demonstrated significantly shorter total procedure time (median 50 vs. 65 min, P < 0.001) and mucosal dissection time (median 40 vs. 56 min, P < 0.001), along with a higher submucosal dissection rate (median 0.12 vs. 0.08 cm²/min, P < 0.001). There were no significant differences in intraoperative perforation, severe hemorrhage, R0 resection, postoperative bleeding, fever, or pathology between the two groups (P > 0.05). Subgroup analyses based on tumor size (2.5 cm and ≥ 2.5 cm) and morphology (LST-G and LST-NG) consistently showed superior efficiency of the IMK technique without compromising safety. The IMK technique significantly improves the efficiency of ESD for rectal LSTs by reducing operative time and enhancing dissection rates, while maintaining comparable safety and outcomes to the conventional DK technique. IMK represents a promising advancement in ESD for rectal lesions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。